Health ❯ Infectious Diseases ❯ Mpox

Transmission

Symptoms Prevention Vaccination Human-to-Human Transmission Public Health Response Clades Clade Ib Epidemiology Risk Factors Public Health

New York City Confirms First Mpox Clade I Case Linked to International Travel

Health officials describe the current risk to residents as low following confirmation of no local transmission.

Brazil Mpox Cases Climb to 88 After Sharp Late-February Increase

La Réunion Confirms Two New Mpox Cases, Total Rises to Six

WHO Flags Recombinant Mpox Variant as Brazil Logs 48 Cases, São Paulo Leads

Porto Alegre Confirms First 2026 Mpox Case as WHO Flags Recombinant Strain

Pakistan Confirms Second Mpox Death, Points to Likely Local Transmission

São Paulo Confirms Second Imported Mpox Clade 1b Case

Berlin Confirms First Mpox Clade Ib Case as Agencies See No Increased Risk

UK Confirms Recombinant Mpox Case Mixing Clade I and II

UKHSA Detects Recombinant Mpox Virus in England After Traveller Returns From Asia

UK Raises Mpox Import Risk as Clade I/Ib Cases Detected Locally in U.S. and Across Europe

California Confirms Three Local Clade I Mpox Cases, Signaling Possible Community Spread

WHO Lifts Mpox Global Emergency After Sustained Declines in Africa

Jalisco Confirms Mexico’s First Mpox Death

Germany Sees Rising Mpox Cases in 2025, Authorities Remain Unalarmed

Berlin Reports 74 Mpox Cases in 2025, Surpassing Last Year’s Total

Mpox Cases Surge in Berlin as Virus Evolves, Raising Global Alarm

WHO Approves Second Mpox Vaccine for Emergency Use

First U.S. Case of Clade I Mpox Confirmed in California

UK Reports First Cluster of New Mpox Variant Outside Africa